CVS Health Corporation

86.40-1.09-1.25%Vol 5.17M1Y Perf -19.66%
Feb 2nd, 2023 12:38 DELAYED
BID86.39 ASK86.40
Open86.54 Previous Close87.49
Pre-Market87.00 After-Market-
 -0.49 -0.56%  - -
Target Price
117.25 
Analyst Rating
Moderate Buy 1.62
Potential %
35.50 
Finscreener Ranking
★+     42.42
Insiders Trans % 3/6/12 mo.
-100/-89/-79 
Value Ranking
     39.68
Insiders Value % 3/6/12 mo.
-100/-99/-98 
Growth Ranking
★★     44.60
Insiders Shares Cnt. % 3/6/12 mo.
-100/-99/-98 
Income Ranking
     31.27
Price Range Ratio 52W %
5.98 
Earnings Rating
Neutral
Market Cap113.53B 
Earnings Date
8th Feb 2023
Alpha0.00 Standard Deviation0.08
Beta0.77 

Today's Price Range

85.4686.97

52W Range

84.82111.25

5 Year PE Ratio Range

-89.2019.20

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-0.19%
1 Month
-6.12%
3 Months
-9.62%
6 Months
-8.26%
1 Year
-19.66%
3 Years
29.00%
5 Years
14.44%
10 Years
76.50%

TickerPriceChg.Chg.%
CVS86.40-1.0900-1.25
AAPL150.044.61013.17
GOOG107.305.87005.79
MSFT261.218.45503.35
XOM112.42-2.3200-2.02
WFC47.380.35000.74
JNJ163.99-0.9300-0.56
FB196.640.99000.51
GE83.310.99001.20
JPM139.25-0.3400-0.24
 
ProfitabilityValueIndustryS&P 500US Markets
17.20
2.00
3.40
2.90
0.78
RevenueValueIndustryS&P 500US Markets
238.62B
181.60
9.47
11.35
DividendsValueIndustryS&P 500US Markets
2.65
2.42
0.24
1.44
Payout ratio35.00
Earnings HistoryEstimateReportedSurprise %
Q03 20221.992.095.03
Q02 20222.162.4011.11
Q01 20222.142.223.74
Q04 20211.941.982.06
Q03 20211.791.9710.06
Q02 20212.072.4216.91
Q01 20211.722.0418.60
Q04 20201.241.304.84
Earnings Per EndEstimateRevision %Trend
12/2022 QR1.91-1.04Negative
12/2022 FY8.621.06Positive
3/2023 QR2.24-0.88Negative
12/2023 FY8.83-4.13Negative
Next Report Date8th Feb 2023
Estimated EPS Next Report1.92
Estimates Count6
EPS Growth Next 5 Years %7.30
Volume Overview
Volume5.17M
Shares Outstanding1.31M
Shares Float1.31B
Trades Count56.41K
Dollar Volume447.13M
Avg. Volume8.29M
Avg. Weekly Volume7.76M
Avg. Monthly Volume10.04M
Avg. Quarterly Volume7.06M

CVS Health Corporation (NYSE: CVS) stock closed at 87.49 per share at the end of the most recent trading day (a -0.83% change compared to the prior day closing price) with a volume of 6.71M shares and market capitalization of 113.53B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 300000 people. CVS Health Corporation CEO is Karen S. Lynch.

The one-year performance of CVS Health Corporation stock is -19.66%, while year-to-date (YTD) performance is -6.12%. CVS stock has a five-year performance of 14.44%. Its 52-week range is between 84.82 and 111.25, which gives CVS stock a 52-week price range ratio of 5.98%

CVS Health Corporation currently has a PE ratio of 39.10, a price-to-book (PB) ratio of 1.70, a price-to-sale (PS) ratio of 0.50, a price to cashflow ratio of 5.50, a PEG ratio of 2.32, a ROA of 1.47%, a ROC of 3.37% and a ROE of 4.72%. The company’s profit margin is 0.78%, its EBITDA margin is 3.40%, and its revenue ttm is $238.62 Billion , which makes it $181.60 revenue per share.

Of the last four earnings reports from CVS Health Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.92 for the next earnings report. CVS Health Corporation’s next earnings report date is 08th Feb 2023.

The consensus rating of Wall Street analysts for CVS Health Corporation is Moderate Buy (1.62), with a target price of $117.25, which is +35.50% compared to the current price. The earnings rating for CVS Health Corporation stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CVS Health Corporation has a dividend yield of 2.65% with a dividend per share of $2.42 and a payout ratio of 35.00%.

CVS Health Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 8.01, ATR14 : 1.55, CCI20 : -53.68, Chaikin Money Flow : -0.16, MACD : -1.94, Money Flow Index : 40.14, ROC : -2.70, RSI : 37.96, STOCH (14,3) : 46.52, STOCH RSI : 0.85, UO : 53.14, Williams %R : -53.48), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CVS Health Corporation in the last 12-months were: Alan M. Lotvin (Option Excercise at a value of $8 245 943), Alan M. Lotvin (Sold 143 440 shares of value $14 192 366 ), Daniel P. Finke (Option Excercise at a value of $2 960 553), Daniel P. Finke (Sold 70 846 shares of value $7 091 795 ), Edward J. Ludwig (Buy at a value of $105 904), Prem S. Shah (Option Excercise at a value of $1 716 473), Prem S. Shah (Sold 26 924 shares of value $2 833 046 ), Thomas M. Moriarty (Option Excercise at a value of $23 903 792), Thomas M. Moriarty (Sold 327 481 shares of value $32 086 214 ), Troyen A. Brennan (Option Excercise at a value of $4 902 037), Troyen A. Brennan (Sold 47 937 shares of value $5 273 070 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
10 (58.82 %)
11 (64.71 %)
10 (62.50 %)
Moderate Buy
3 (17.65 %)
3 (17.65 %)
4 (25.00 %)
Hold
4 (23.53 %)
3 (17.65 %)
2 (12.50 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.62
Strong Buy
1.50
Strong Buy
1.47

CVS Health Corporation

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with over 23 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

CEO: Karen S. Lynch

Telephone: +1 401 765-1500

Address: One CVS Drive, Woonsocket 02895, RI, US

Number of employees: 300 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

65%35%

Bearish Bullish

58%42%

Bearish Bullish

58%42%

TipRanks News for CVS

Tue, 08 Nov 2022 12:45 GMT CVS Health (CVS) Receives a Hold from Wells Fargo

- TipRanks. All rights reserved.

Sat, 17 Sep 2022 13:17 GMT IBM, CVS among cheap stocks not deserving to be in bargain bin, Barrons says

- TipRanks. All rights reserved.

Mon, 05 Sep 2022 06:43 GMT CVS Health (NYSE:CVS) Races Ahead to Buy Signify Health

- TipRanks. All rights reserved.

Fri, 05 Aug 2022 12:45 GMT CVS Health (CVS) Receives a Buy from Jefferies

- TipRanks. All rights reserved.

Mon, 04 Jul 2022 22:17 GMT CVS Health Stock: A Recession-Proof Cash Cow

- TipRanks. All rights reserved.

News

Stocktwits